Ovarian Neoplasm Epithelial Borderline

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Ovarian Neoplasm Epithelial Borderline trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT05500391

Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

This is a multicenter, interventional, randomized study among adult patients recently diagnosed with a rare tumor (\<12 months). The study will aim to compare c…

France88 participantsStarted 2024-02-28

Treatment: Oncological Follow-up

All recent trials (32 shown)

CompletedNot Applicable

NCT04253327

Distress, Anxiety and Psychosexual Health in BOT

The aim of this study is to assess the prevalence of distress, anxiety and psychosexual anguish in patients diagnosed with borderline ovarian tumor (BOT) compar…

Belgium60 participantsStarted 2020-09-01

Treatment: questionnaire

Active — Not RecruitingNot Applicable

NCT03883542

Sub-type Specific Genomic Mutations in sBOTs

The aim of this study is to identify different origin in carcinogenesis between serous borderline ovarian tumors presenting a. without implants, b. with non-inv…

Belgium20 participantsStarted 2017-01

Treatment: genomic mutations study

Ovarian Neoplasm Epithelial Borderline

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

All recent trials (32 shown)

Distress, Anxiety and Psychosexual Health in BOT

Sub-type Specific Genomic Mutations in sBOTs

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

All recent trials (32 shown)

Distress, Anxiety and Psychosexual Health in BOT

Sub-type Specific Genomic Mutations in sBOTs

Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating…

Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer

Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer

Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer

Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian…

Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previ…

Treg, Th17 Cells, NKT in Epithelial Ovarian Tumor

A Genomic Analysis of Evolution of Epithelia Ovarian Tumors

Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer

Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Ca…

Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer

Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer

High-dose ICE With Amifostine

Collecting Tumor Samples From Patients With Gynecological Tumors

Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer

Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Perito…

Immunotoxin Therapy in Treating Patients With Advanced Cancer